(Q53627194)

16 May 2018

review article

1 reference

title

Gastrointestinal Manifestations of Cystic Fibrosis. (English)

1 reference

16 May 2018

0 references

Thomas Kelly

1

1 reference

16 May 2018

James Buxbaum

series ordinal

2

1 reference

16 May 2018

publication date

4 February 2015

1 reference

16 May 2018

Digestive Diseases and Sciences

published in

1 reference

16 May 2018

volume

60

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1903-1913

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-015-3546-7

exact match

0 references

cites work

Cystic Fibrosis Heterozygote Resistance to Cholera Toxin in the Cystic Fibrosis Mouse Model

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Patterns of GI disease in adulthood associated with mutations in the CFTR gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

The adult cystic fibrosis patient with abdominal pain: what the radiologist needs to know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Abdominal manifestations of cystic fibrosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Nutrition in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Gastroesophageal reflux in cystic fibrosis: current understandings of mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Mechanisms of gastro-oesophageal reflux in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Gastroesophageal reflux and respiratory disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Small-intestinal abnormalities in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Abdominal manifestations of cystic fibrosis in adults: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Review of the abdominal manifestations of cystic fibrosis in the adult patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Issues in the management of simple and complex meconium ileus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Meconium ileus in the absence of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

The impact of cystic fibrosis on neonatal intestinal obstruction: the need for prenatal/neonatal screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Abdominal calcification in cystic fibrosis with meconium ileus: radiologic-pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Management and survival of meconium ileus. A 30-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Distal intestinal obstruction syndrome in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Characteristics of lipid substances activating the ileal brake in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Rectal prolapse in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Intussusception in adults with cystic fibrosis: a case series with review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

The spectrum of appendiceal disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Appendix in children with cystic fibrosis: US features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Colonic disorders in adult cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Fibrosing colonopathy in cystic fibrosis: results of a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Application of the glucose hydrogen breath test for the detection of bacterial overgrowth in patients with cystic fibrosis--a reliable method?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

The Risk of Cancer among Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Colon cancer in lung transplant recipients with CF: increased risk and results of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Hepatobiliary complications of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Pulmonary diseases and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Cystic fibrosis-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Genetic modifiers of liver disease in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Ursodeoxycholic acid for cystic fibrosis-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

A review of abdominal organ transplantation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Intrahepatic biliary stones in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Liver disease and common-bile-duct stenosis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Fatty acids in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Gallstones in cystic fibrosis: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-3546-7

Biliary tree in cystic fibrosis. Biliary tract abnormalities in cystic fibrosis demonstrated by endoscopic retrograde cholangiography

21 January 2018

1 reference

12 December 2020

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes

1 reference

12 December 2020

Radiographic abnormalities of the duodenum in cystic fibrosis

1 reference

12 December 2020

Liver disease in cystic fibrosis

1 reference

12 December 2020

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis

1 reference

12 December 2020

Massive hepatomegaly, steatosis, and secondary plasma carnitine deficiency in an infant with cystic fibrosis

1 reference

12 December 2020

Ultrasonography detects appendicular mucocele in cystic fibrosis patients suffering recurrent abdominal pain

1 reference

12 December 2020

Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes

1 reference

12 December 2020

Successful endoscopic therapy of cholangitis associated with intrahepatic cholangiectasis in adult cystic fibrosis

1 reference

12 December 2020

Gastrointestinal manifestations of cystic fibrosis

1 reference

12 December 2020

The changing epidemiology of recurrent pyogenic cholangitis

1 reference

12 December 2020

Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome

1 reference

12 December 2020

Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis

1 reference

12 December 2020

Gastrointestinal findings in cystic fibrosis

1 reference

12 December 2020

Cystic fibrosis: nutritional consequences and management

1 reference

12 December 2020

Treatment and prognosis of rectal prolapse in cystic fibrosis

1 reference

12 December 2020

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group

1 reference

12 December 2020

A Study of Recurrent Pyogenic Cholangitis

1 reference

12 December 2020

Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis

1 reference

12 December 2020

Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation

1 reference

12 December 2020

Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells

1 reference

12 December 2020

Gastrointestinal manifestations of cystic fibrosis

1 reference

12 December 2020

Pancreatic fluid secretion and protein hyperconcentration in cystic fibrosis

1 reference

12 December 2020

Clinical and Genetic Characteristics of Meconium Ileus in Newborns With and Without Cystic Fibrosis

1 reference

12 December 2020

Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program

1 reference

12 December 2020

Natural history of liver disease in cystic fibrosis

1 reference

12 December 2020

10.1007/S10620-015-3546-7

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018